National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 8) (PB 108 of 2016) (Cth)

PB 108 of 2016

National Health Determination under paragraph 98C(1)(b) Amendment 2016
(No. 8)
_____________________________________________________________________

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated   28    November                   2016

PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2016 (No. 8).

(2)This Instrument may also be cited as PB 108 of 2016.

2              Commencement  

This instrument commences on 1 December 2016.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 4, omit entry for Homatropine

2. Schedule 4, after entry for Leuprorelin

   insert

Leuprorelin and bicalutamide	Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg
Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg
Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg